Applied Therapeutics Stock Market Value
| APLT Stock | USD 9.63 0.36 3.88% |
| Symbol | Applied |
Applied Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied Therapeutics. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.42) | Revenue Per Share (0) | Quarterly Revenue Growth (0.98) | Return On Assets (0.76) | Return On Equity (4.73) |
The market value of Applied Therapeutics is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Applied Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied Therapeutics' market value can be influenced by many factors that don't directly affect Applied Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Applied Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Applied Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Applied Therapeutics.
| 05/04/2023 |
| 11/24/2024 |
If you would invest 0.00 in Applied Therapeutics on May 4, 2023 and sell it all today you would earn a total of 0.00 from holding Applied Therapeutics or generate 0.0% return on investment in Applied Therapeutics over 570 days. Applied Therapeutics is related to or competes with X4 Pharmaceuticals, Terns Pharmaceuticals, Day One, Hookipa Pharma, Lyra Therapeutics, Shattuck Labs, and Vincerx Pharma. Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular... More
Applied Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Applied Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Applied Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.38 | |||
| Information Ratio | 0.1093 | |||
| Maximum Drawdown | 78.72 | |||
| Value At Risk | (6.33) | |||
| Potential Upside | 5.6 |
Applied Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Applied Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Applied Therapeutics' standard deviation. In reality, there are many statistical measures that can use Applied Therapeutics historical prices to predict the future Applied Therapeutics' volatility.| Risk Adjusted Performance | 0.104 | |||
| Jensen Alpha | 1.09 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.229 | |||
| Treynor Ratio | 4.19 |
Applied Therapeutics Backtested Returns
Applied Therapeutics is unstable given 3 months investment horizon. Applied Therapeutics secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 1.06% are justified by taking the suggested risk. Use Applied Therapeutics Downside Deviation of 4.38, mean deviation of 3.83, and Risk Adjusted Performance of 0.104 to evaluate company specific risk that cannot be diversified away. Applied Therapeutics holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Applied Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Applied Therapeutics is expected to be smaller as well. Use Applied Therapeutics semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on Applied Therapeutics.
Auto-correlation | 0.65 |
Good predictability
Applied Therapeutics has good predictability. Overlapping area represents the amount of predictability between Applied Therapeutics time series from 4th of May 2023 to 13th of February 2024 and 13th of February 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Applied Therapeutics price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Applied Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.65 | |
| Spearman Rank Test | 0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 2.79 |
Applied Therapeutics lagged returns against current returns
Autocorrelation, which is Applied Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Applied Therapeutics' stock expected returns. We can calculate the autocorrelation of Applied Therapeutics returns to help us make a trade decision. For example, suppose you find that Applied Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Applied Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Applied Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Applied Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Applied Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Applied Therapeutics Lagged Returns
When evaluating Applied Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Applied Therapeutics stock have on its future price. Applied Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Applied Therapeutics autocorrelation shows the relationship between Applied Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Applied Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.